ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,374.00
-0.06%
S&P ASX All Technology
3,953.80
1.34%
Brent Oil
75.025
-0.44%
US Dollar vs AUD
1.61121
0.18%
Bitcoin
98,372.65
-3.01%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Genedrive Plc (GDR) Share Price

Genedrive Plc

Genedrive Plc (GDR)

LSE
2.20
0.00
(0.00%)
Closed 04 February 3:30AM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
2.20
Bid
2.10
Offer
2.25
Volume
0.00
0.00 Day's Range 0.00
1.425 52 Week Range 9.75
Market Cap
11.949M
Previous Close
2.20
Open
-
Last Trade
(O)
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
5,153,053
Shares Outstanding
543,141,481
Dividend Yield
-
PE Ratio
-1.69
Earnings Per Share (EPS)
-0.01
Revenue
501k
Net Profit
-7.08M

About Genedrive Plc

Sector
Coml Physical, Biologcl Resh
Industry
Coml Physical, Biologcl Resh
Website
www.genedriveplc.com
Headquarters
Manchester, Gbr
Founded
-
Genedrive Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker GDR. The last closing price for Genedrive was 2.20p. Over the last year, Genedrive shares have traded in a share price range of 1.425p to 9.75p.

Genedrive currently has 543,141,481 shares in issue. The market capitalisation of Genedrive is £11.95 million. Genedrive has a price to earnings ratio (PE ratio) of -1.69.

Ask ADVFN Intelligence (AI)

GDR Latest News

More News

Genedrive PLC Result of AGM

Genedrive PLC 30 December 2024   genedrive plc ("genedrive" or the "Company")   Result of AGM   genedrive plc (AIM: GDR), the point of care pharmacogenetic testing company, announces that at...

30 December 2024
RNS Regulatory News

Genedrive shares rise on positive results for genetic testing kit

Genedrive PLC on Friday said its CYP2C19-ID genetic testing kit has shown superior performance compared to laboratory ...

27 December 2024
Alliance News

Genedrive PLC Genedrive® CYP2C19-ID Kit performance published

Genedrive PLC 27 December 2024   genedrive plc ("genedrive" or the "Company")   Genedrive® CYP2C19-ID Kit clinical performance published Superior performance to laboratory test and alternative...

27 December 2024
RNS Regulatory News

Genedrive PLC Grant of Options

Genedrive PLC 20 December 2024   genedrive plc ("genedrive" or the "Company")   Notification and public disclosure of transactions by persons discharging managerial responsibilities and...

20 December 2024
RNS Regulatory News

Genedrive PLC Director/PDMR Shareholding

Genedrive PLC 20 December 2024   genedrive plc ("genedrive" or the "Company")   Director/PDMR Notification   genedrive plc (AIM: GDR), the point of care pharmacogenetic testing company...

20 December 2024
RNS Regulatory News

Genedrive PLC Posting of annual report and notice of AGM

Genedrive PLC 05 December 2024     genedrive plc ("genedrive" or the "Company")   Posting of Annual Report and Accounts and notice of AGM   genedrive plc (AIM: GDR), the point of care...

06 December 2024
RNS Regulatory News

Genedrive PLC Block listing returns

Genedrive PLC 29 November 2024     genedrive plc ("genedrive" or the "Company")   Block Listing Returns   The Company confirms the block listing six monthly return for the period to 29...

30 November 2024
RNS Regulatory News

Genedrive annual loss widens due to increased expenses

Genedrive PLC on Friday said its loss widened during its most recent financial year, as its expenses ramped up. The ...

29 November 2024
Alliance News

Genedrive PLC Final Results

Genedrive PLC 29 November 2024   genedrive plc ("genedrive" or "the Company" or "the Group")   Audited Final Results   genedrive plc (AIM: GDR), the point of care pharmacogenetic testing...

29 November 2024
RNS Regulatory News

Genedrive PLC Notice of Results

Genedrive PLC 22 November 2024     genedrive plc ("genedrive" or the "Company")   Notice of Results Investor Presentation   genedrive plc (AIM: GDR), the point of care pharmacogenetic testing...

22 November 2024
RNS Regulatory News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.14.76190476192.12.3752.07531868072.21208566DE
4-0.2-8.333333333332.42.42.02530429842.17789884DE
120.0753.529411764712.1252.751.79551530532.24054523DE
26-1.1-33.33333333333.33.8251.7594730202.56856679DE
52-4.3-66.15384615386.59.751.425131741002.90129014DE
156-19.3-89.767441860521.548.51.42555142286.42124639DE
260-10.3-82.412.52991.425416259319.04948977DE

GDR - Frequently Asked Questions (FAQ)

What is the current Genedrive share price?
The current share price of Genedrive is 2.20p
How many Genedrive shares are in issue?
Genedrive has 543,141,481 shares in issue
What is the market cap of Genedrive?
The market capitalisation of Genedrive is GBP 11.95M
What is the 1 year trading range for Genedrive share price?
Genedrive has traded in the range of 1.425p to 9.75p during the past year
What is the PE ratio of Genedrive?
The price to earnings ratio of Genedrive is -1.69
What is the cash to sales ratio of Genedrive?
The cash to sales ratio of Genedrive is 24.44
What is the reporting currency for Genedrive?
Genedrive reports financial results in GBP
What is the latest annual turnover for Genedrive?
The latest annual turnover of Genedrive is GBP 501k
What is the latest annual profit for Genedrive?
The latest annual profit of Genedrive is GBP -7.08M
What is the registered address of Genedrive?
The registered address for Genedrive is THE CTF BUILDING, GRAFTON STREET, MANCHESTER, M13 9XX
What is the Genedrive website address?
The website address for Genedrive is www.genedriveplc.com
Which industry sector does Genedrive operate in?
Genedrive operates in the COML PHYSICAL, BIOLOGCL RESH sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
0A2IH World Group Ltd
US$ 0.00
(0.00%)
0
0A2DCrh Plc
US$ 0.00
(0.00%)
0
0A2BBanco Bilbao Vizcaya Argentaria Sa
US$ 0.00
(0.00%)
0
0A22Anheuser Busch Inbev Nv
US$ 0.00
(0.00%)
0
0A1UUber Technologies Inc
US$ 68.35
(0.00%)
675
0A2IH World Group Ltd
US$ 0.00
(0.00%)
0
0A2DCrh Plc
US$ 0.00
(0.00%)
0
0A2BBanco Bilbao Vizcaya Argentaria Sa
US$ 0.00
(0.00%)
0
0A22Anheuser Busch Inbev Nv
US$ 0.00
(0.00%)
0
0A1UUber Technologies Inc
US$ 68.35
(0.00%)
675
0R2VApple Inc
US$ 228.50
(0.00%)
5.78k
0HCIAlibaba Group Holding Ltd
US$ 95.50
(0.00%)
5.73k
0R0XTesla Inc
US$ 384.40
(0.00%)
5.02k
ROADRoadside Real Estate Plc
30.20p
(0.00%)
3.5k
0R24Intel Corp
US$ 19.575
(0.00%)
2.68k

Discussion

View Full Feed
GrandAdmiralThrawn GrandAdmiralThrawn 5 minutes ago
I’m ready for today, let’s do this.
CLHI
WojD40 WojD40 10 minutes ago
You’re right that you can read it both ways and it means the same thing. It’s hard not to conclude the FDA application is being held back, or in some pre-submission state, in order to improve its chances. Be that manufacturing readiness, additional (specials?) data, or combo data. I hope the compan
NWBO
silattore silattore 13 minutes ago
Take your TDS and shove it up
XRPUSD
jog49 jog49 17 minutes ago
"Why is the fhfa wings not cut yet while cfpb alone was?"

Source of funding, I would say.
FNMA
The_Pro The_Pro 19 minutes ago
I would rather DewmBoom back versus Claytrader. Oldies will know him.

Great asset to this board.
BIEL
Researchfyi Researchfyi 21 minutes ago
So tell me. What has the company done for investors repetitiously?

I would tell you the answers, but I love to hear your carry the water for them replies.

Then again you know the answers from reading my posts.
LQMT
diamondguru-one diamondguru-one 22 minutes ago
New-WMI IPO offering to UQ escrow holders from the WMI-LT in Plan 6/DST/DCR.

The Possibility;
+$40/1.215 = $32.9 opening share price.
MC =+$40 Billion in hard assets

what's your thoughts on the share ratio ???

1 for 1
5 for 1
COOP
jog49 jog49 22 minutes ago
"We need to message ackman and tell him to shut the Fudge up about the warrants"

Thank you!
FNMA
DruidOracle55 DruidOracle55 22 minutes ago
1 million years
AXXA
benz280e benz280e 23 minutes ago
Fully reporting for 2025, on Melvins typical no communication procrastination calendar could very well mean March 15, 2026, more than an entire year from now, if ever at all...
GDVM
RickNagra RickNagra 24 minutes ago
Oh wow.  Incoming $$99 on deck.  Of oh wow amazing I will be a millionaire or maybe more hard to say in these times and the future is always going to be better for me.  DBMM is a great project and company to own and support the community and the team is very strong.  Best to win and own millions of
DBMM
nowwhat2 nowwhat2 25 minutes ago
https://investorshub.advfn.com/uimage/uploads/2025/2/4/vzkfptot_@_3_6m_11pm_bounce_then_whump.jpg




XRP 2.50 Baby.........HODL the bucking bronco !

https://investorshub.advfn.com/uimage/uploads/2025/2/4/ftxmxXRP_@_3_TRIO_930PM_100K_250_WHUMP.jpg
XRPUSD
pgsd pgsd 28 minutes ago
US biosimilar 'void' spells trouble as biologic patent expirations loom, IQVIA report says :
February 3, 2025

While 118 biologics are expected to lose patent protection in the US over the next decade, that $234 billion opportunity for biosimilar developers may not materialize b
NWBO
ham n slam ham n slam 29 minutes ago
people keep mentioning the high end piece of tail babs."..keep in mind 36 mil shares is one percent of the float...Emil holds 1 bil so 2.5 bil is out there on the garage sale table. alot of shares, imo..my gut tells me she can sell but why?hang on babs! you don't need a new wardrobe just yet!! chill
VPLM
oldmystic oldmystic 32 minutes ago
5.64 yes https://invst.ly/18qz13
https://media.stocktwits-cdn.com/api/3/media/1740042/medium.jpeg
AVXL
Investor082 Investor082 33 minutes ago
It’s funny how conversations always shift to manipulators or what retailers should do rather than what LP and the management team does for the shareholders. If they do not have non dilutive funds lined up after 4.5 years post data lock, and almost 3 years since TLD then LP has failed shareholders. N
NWBO
IceCold8 IceCold8 35 minutes ago
Some of us are filing complaints https://www.finra.org/investors/need-help/file-a-complaint I thought the market was bad under FJB, I'm thinking it's going to be even worse under this one,and I'm hoping I'm seriously wrong!
CGAC
doccjc doccjc 46 minutes ago
Great,,, I had sent a message on X,,, glad they fixed it,,
I can't get over the 80% reduction in tumor size and metastatic activity in 30 days !
RDGL
bbotcs bbotcs 48 minutes ago
mankind: Greenland 51st State, not Canada!
dinogreeves dinogreeves 48 minutes ago
Market is reversing into positive territory, reversing 80 point loss on Nasdaq, must be something cooking with these two super powers.
SMCI
bbotcs bbotcs 50 minutes ago
Gmenfan: Well the victims of the procedures will be able to sue her down the road.
nowwhat2 nowwhat2 51 minutes ago
When did he post that ?.......

https://investorshub.advfn.com/uimage/uploads/2025/2/4/dkzyqeth_@_3_duo_11pm_trump_said_buy_when.jpg


Answer - YUP !



Guy shouldn't even be ALLOWED to run around posting chit like that !

ETHUSD
bbotcs bbotcs 51 minutes ago
lj: I think Trump is looking at a U.S.-Canadian merger. Canada is a political Disneyland. This would be a good time for Quebec to go indy.
bbotcs bbotcs 53 minutes ago
lj: I think it was cancelled for this area. Film at 11.
mikepgator mikepgator 55 minutes ago
Nevermind, I emailed and got confirmation that it has been fixed.
RDGL

Your Recent History

LSE
GDR
Genedrive
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads